Two cases of neural tube defects with dolutegravir use at conception in south Brazil

Detalhes bibliográficos
Autor(a) principal: Kreitchmann,Regis
Data de Publicação: 2021
Outros Autores: Oliveira,Fernando Rocha de, Sprinz,Eduardo
Tipo de documento: Relatório
Idioma: eng
Título da fonte: Brazilian Journal of Infectious Diseases
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702021000200401
Resumo: ABSTRACT Dolutegravir (DTG) is amongst the most prescribed antiretrovirals worldwide and is recommended as first line regimen in most HIV treatment guidelines. Its use, although infrequently, had been associated to an increased chance of neural tube defects (NTD) in Botswana, Africa. Herein we describe two cases of NTD in women who conceived while taking DTG as part of their antiretroviral treatment in the city of Porto Alegre, Brazil.
id BSID-1_69fb493e733083319009c314d5d08c25
oai_identifier_str oai:scielo:S1413-86702021000200401
network_acronym_str BSID-1
network_name_str Brazilian Journal of Infectious Diseases
repository_id_str
spelling Two cases of neural tube defects with dolutegravir use at conception in south BrazilHIVNeural tube defectsPregnancyDolutegravirABSTRACT Dolutegravir (DTG) is amongst the most prescribed antiretrovirals worldwide and is recommended as first line regimen in most HIV treatment guidelines. Its use, although infrequently, had been associated to an increased chance of neural tube defects (NTD) in Botswana, Africa. Herein we describe two cases of NTD in women who conceived while taking DTG as part of their antiretroviral treatment in the city of Porto Alegre, Brazil.Brazilian Society of Infectious Diseases2021-01-01info:eu-repo/semantics/reportinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702021000200401Brazilian Journal of Infectious Diseases v.25 n.2 2021reponame:Brazilian Journal of Infectious Diseasesinstname:Brazilian Society of Infectious Diseases (BSID)instacron:BSID10.1016/j.bjid.2021.101572info:eu-repo/semantics/openAccessKreitchmann,RegisOliveira,Fernando Rocha deSprinz,Eduardoeng2021-06-16T00:00:00Zoai:scielo:S1413-86702021000200401Revistahttps://www.bjid.org.br/https://old.scielo.br/oai/scielo-oai.phpbjid@bjid.org.br||lgoldani@ufrgs.br1678-43911413-8670opendoar:2021-06-16T00:00Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)false
dc.title.none.fl_str_mv Two cases of neural tube defects with dolutegravir use at conception in south Brazil
title Two cases of neural tube defects with dolutegravir use at conception in south Brazil
spellingShingle Two cases of neural tube defects with dolutegravir use at conception in south Brazil
Kreitchmann,Regis
HIV
Neural tube defects
Pregnancy
Dolutegravir
title_short Two cases of neural tube defects with dolutegravir use at conception in south Brazil
title_full Two cases of neural tube defects with dolutegravir use at conception in south Brazil
title_fullStr Two cases of neural tube defects with dolutegravir use at conception in south Brazil
title_full_unstemmed Two cases of neural tube defects with dolutegravir use at conception in south Brazil
title_sort Two cases of neural tube defects with dolutegravir use at conception in south Brazil
author Kreitchmann,Regis
author_facet Kreitchmann,Regis
Oliveira,Fernando Rocha de
Sprinz,Eduardo
author_role author
author2 Oliveira,Fernando Rocha de
Sprinz,Eduardo
author2_role author
author
dc.contributor.author.fl_str_mv Kreitchmann,Regis
Oliveira,Fernando Rocha de
Sprinz,Eduardo
dc.subject.por.fl_str_mv HIV
Neural tube defects
Pregnancy
Dolutegravir
topic HIV
Neural tube defects
Pregnancy
Dolutegravir
description ABSTRACT Dolutegravir (DTG) is amongst the most prescribed antiretrovirals worldwide and is recommended as first line regimen in most HIV treatment guidelines. Its use, although infrequently, had been associated to an increased chance of neural tube defects (NTD) in Botswana, Africa. Herein we describe two cases of NTD in women who conceived while taking DTG as part of their antiretroviral treatment in the city of Porto Alegre, Brazil.
publishDate 2021
dc.date.none.fl_str_mv 2021-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/report
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format report
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702021000200401
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702021000200401
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1016/j.bjid.2021.101572
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Brazilian Society of Infectious Diseases
publisher.none.fl_str_mv Brazilian Society of Infectious Diseases
dc.source.none.fl_str_mv Brazilian Journal of Infectious Diseases v.25 n.2 2021
reponame:Brazilian Journal of Infectious Diseases
instname:Brazilian Society of Infectious Diseases (BSID)
instacron:BSID
instname_str Brazilian Society of Infectious Diseases (BSID)
instacron_str BSID
institution BSID
reponame_str Brazilian Journal of Infectious Diseases
collection Brazilian Journal of Infectious Diseases
repository.name.fl_str_mv Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)
repository.mail.fl_str_mv bjid@bjid.org.br||lgoldani@ufrgs.br
_version_ 1754209245186752512

Registros relacionados